Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: A retrospective cohort study

Journal of Investigative Dermatology

Volumn 132, Issue 9, 2012, Pages 2166-2170

  Langan, Sinéad M ^a   Groves, Richard W ^b   Card, Tim R ^c   Gulliford, Martin C ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; ENTERITIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCHOOL CHILD; UNITED KINGDOM;

EID: 84865331325     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.130     Document Type: Article

References (20)

1. Bath-Hextall F, Leonardi-Bee J, Smith C et al. (2007) Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 121:2105-8
2. Bennett ML, Jackson JM, Jorizzo JL et al. (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79:37-46
3. Bernstein CN, Blanchard JF, Rawsthorne P et al. (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a populationbased study. Am J Gastroenterol 96:1116-22
4. Brooklyn T, Dunnill G, Probert C (2006) Diagnosis and treatment of pyoderma gangrenosum. BMJ 333:181-4
5. Callen JP (1998) Pyoderma gangrenosum. Lancet 351:581-5
6. Charlson M, Pompei P, Ales K et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-83
7. Farhi D, Cosnes J, Zizi N et al. (2008) Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2,402 patients. Medicine (Baltimore) 87:281-93
8. General Practice Research Database (2011). http://www.gprd.com/products/ database.asp (accessed 14 July 2011)
9. Herrett E, Thomas S, Schoonen W et al. (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69:4-14
10. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14:1707-23
11. Jick S, Kaye J, Vasilakis-Scaramozza C et al. (2003) Validity of the general practice research database. Pharmacotherapy 23:686-9
12. Lewis J, Bilker W, Weinstein R et al. (2005) The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14:443-51
13. Lewis J, Brensinger C, Bilker W et al. (2002) Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 11:211-8
14. Powell FC, Schroeter AL, Su WP et al. (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55:173-86
15. Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34:395-409
16. Saracino A, Kelly R, Liew D et al. (2011) Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol 52:218-21
17. Vavricka SR, Brun L, Ballabeni P et al. (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106:110-9
18. von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137:1000-5
19. Weenig RH, Davis MD, Dahl PR et al. (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 347:1412-8
20. Yüksel I, deg;ar O, Ataseven H et al. (2009) Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis 15:546-50